Life Sciences have a new big player: Joint Polish Investment Fund Management

23/03/2015 - 3 minutes

Poland’s first Institutional Venture Capital Fund dedicated to Life Sciences announced today the first closing of its new venture capital fund at €38.5M. Joint Polish Investment Fund Management (JPIF), headed by Dr. Marek Orłowski, is the first institutional venture capital fund operating out of Poland that is completely dedicated to life science investments.

The fund will invest in early and mid-stage companies with a close relationship to Poland and marks an important milestone on the country’s path to further strengthen its life science industry. Investment activities will focus on areas with strong growth, relatively short holding periods and high return potential.

JPIF is backed and supported by the National Centre for Research and Development (NCBR), an executive agency of the Ministry of Science and Higher Education of Poland and supports national science as well as general innovation policies.

Participation of Venture Capital funds in the development and commercialization of new technologies is of key importance because the private funding adds to the public money,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member